Business Wire

Bureau Veritas Partners with Avitas Systems, a GE Venture, to Create the Next Generation of Inspection Services Driven by Advanced Analytics

Jaa

Today, Bureau Veritas, a world leader in testing, inspection, and certification services, and Avitas Systems, a GE Venture, announced a strategic alliance to bring to market cross-industry, analytics-based inspection. This partnership will provide enhanced end-to-end inspection services to customers at a global scale.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171204006007/en/

John Spirtos, President, Avitas Systems (left) and Philippe Donche-Gay, Senior Executive Vice Presid ...

John Spirtos, President, Avitas Systems (left) and Philippe Donche-Gay, Senior Executive Vice President, international Operations & Support, at Bureau Veritas (right) sign their partnership (Photo: Business Wire)

Through the partnership, Bureau Veritas will advance its independent inspection services with the Avitas Systems cloud-based platform, combining automated data collection and artificial intelligence techniques to bring continuous industrial risk management to a new level for asset owners.

Avitas Systems will provide technologies, including sensors, drones, and other robotics, paired with deep learning-based data analytics to automatically recognize asset defects and deliver results via an online interface with user-accessible data and reporting. New technologies will prevent inspectors from working in high-risk and repetitive working conditions, which will improve overall safety and efficiency.

“We are very excited to partner with Bureau Veritas, especially given its global reach and reputation for industry-leading inspection and certification,” said Alex Tepper, Founder and Head of Corporate and Business Development at Avitas Systems. “By combining resources, we will have an unrivaled digital inspection offering.”

Bureau Veritas will provide its deep-rooted, global expertise in industrial assets, notably in visual inspection and non-destructive testing, to create a wide range of integrity assessment models and upgraded services using Avitas Systems technologies.

The joint offering will initially focus on electric power and utility assets, notably renewable energy, and will progressively expand to other industrial assets.

“Digital transformation is a unique opportunity for our customers and business sector to redefine the way asset integrity and performance are managed, while improving the safety of inspectors on the field,” said Joerg Gmeinbauer, Global Market Lead, Power & Utilities at Bureau Veritas. “This next generation of inspection services will revolutionize the way industries monitor their assets, while enabling us to make our core mission of risk reduction and performance improvement a reality in the digitalized world.”

About Avitas Systems, a GE Venture

Avitas Systems is a GE Venture advancing the inspection services industry across oil and gas, transportation, and electric power sectors through predictive data analytics, robotics, and artificial intelligence. Its solutions increase safety and decrease inspection costs by providing state-of-the-art robotic-based autonomous and semi-autonomous inspection management, smart scheduling, and a cloud-based platform that analyzes and stores comprehensive inspection data. Avitas Systems delivers advanced insights based on anticipated risk, boosting facility productivity. For more information, visit http://www.avitas-systems.com/, or follow on Twitter (@Avitas_Systems) and LinkedIn.

About Bureau Veritas

Bureau Veritas is a world leader in laboratory testing, inspection and certification services. Created in 1828, the Group has 74,000 employees located in 1,400 offices and laboratories around the globe. Bureau Veritas helps its clients improve their performance by offering services and innovative solutions in order to ensure that their assets, products, infrastructure and processes meet standards and regulations in terms of quality, health and safety, environmental protection and social responsibility. Bureau Veritas is listed on Euronext Paris and belongs to the Next 20 index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.

For more information, visit http://www.bureauveritas.com, or follow on Twitter (@BureauVeritas) and LinkedIn.

Contact information

Avitas Systems, a GE Venture
Dominique Mann, 202-316-7103
dominique.mann@ge.com
or
Bureau Veritas Group, Media:
Delphine Schroeder, +33 (0)6 82 51 65 29
delphine.schroeder@dscommunication.fr
or
Delphine Sacleux, +33 (0)6 71 10 80 03
delphine.sacleux@dscommunication.fr
or
Véronique Gielec, +33 (0)1 55 24 76 01
veronique.gielec@bureauveritas.com
or
Bureau Veritas Group, Analysts/Investors:
Laurent Brunelle, +33 (0)1 55 24 76 09
laurent.brunelle@bureauveritas.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar16.12.2017 01:13Tiedote

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 15:34Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 15:21Tiedote

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 14:38Tiedote

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 14:00Tiedote

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 12:00Tiedote

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme